Multicentre experience with a simple blood salvage technique in patients with ruptured ectopic pregnancy in sub‐Sahelian West Africa

Priuli, Gianbattista; Darate, R.; Perrin, René Xavier; Lankoandé, J.; Drouet, N.

doi:10.1111/j.1423-0410.2009.001215.x

Cited by 15 publications

(22 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This study also reflects actually what happens in other countries in sub-Saharan Africa where Pruli,G. et al, carried similar multicentred study using patients with ruptured ectopic pregnancy [17]. Although it is becoming relativelyuncommon in developed countries due to current advances made in the blood screening processes, autologous blood transfusion constitutes about 5-10% of the total annual blood transfusion in the United States [12][13][14].…”

Section: Discussionsupporting

confidence: 81%

“…However, very few studies have been done in sub-Saharan West Africa where IOBS method of autotransfusion was used to correct anaemia due to haemorrhage from ruptured ectopic pregnancy in two hundred and twelve patients (212). This study showed that autologous blood transfusion did not only improve the haemoglobin concentration of the severely anaemic patients but was a safe method of blood transfusion with minimal TTIs [17].…”

Section: Hematology and Leukemia Issn 2052-434xmentioning

confidence: 70%

See 1 more Smart Citation

Taming the tide of HIV and TTI scourge in Sub-Saharan Africa using autologous blood transfusion

Nwabuko¹,

Nnoli²,

Adaunwo³

et al. 2013

Hematol Leuk

View full text Add to dashboard Cite

Background and objective: The re-emergence of Transfusion Transmissible Infections (TTIs) and Human Immunodeficiency Virus (HIV) through allogeneic blood transfusion has made the subject of autologous blood transfusion to begin to gain adequate attention globally in recent times. This study aimed at enlightening the public on the importance of Autologous blood transfusion as a strategy in curbing HIV, TTI and allogeneic blood transfusion reaction in sub-saharan Africa where poor screening of blood contributes to their spread. To ascertain the suitability of autologous blood transfusion as a safe blood transfusion strategy, the whole essence of which is to achieve better quality of care for our patients. Methodology: The study was divided into 2 parts, one was questionnaire-driven and the other was on the use of Autologous blood transfusion.A total of 40 patients (30 of whom were HIV sero-positive while 10 were HIV sero-negative) aged between 19-55years were randomly recruited for this study in the

show abstract

Section: Discussionsupporting

confidence: 81%

Section: Hematology and Leukemia Issn 2052-434xmentioning

confidence: 70%

Taming the tide of HIV and TTI scourge in Sub-Saharan Africa using autologous blood transfusion

Nwabuko¹,

Nnoli²,

Adaunwo³

et al. 2013

Hematol Leuk

View full text Add to dashboard Cite

show abstract

“…The experience in St. John of God Hospital, Tanguiéta, Benin Republic in salvaging intraperitoneal blood with a perforated metallic conical funnel in 212 patients has shown that the incidence of allogenic blood use is reduced. The postoperative hemoglobin level increased to 84.7 ± 10.5 g/L 6 days postoperatively from a preoperative level of 70.6 ± 18.7 g/L after the transfusion of 681 ± 389 mL (n = 212) of salvaged blood 96. A review97 showed that intraoperative blood salvage (IBS) and ABT is a simple, effective, and safe method of blood replacement and that its use should be of primary consideration in the management of ruptured ectopic pregnancy.…”

Section: Challenges Of Suboptimal Use Of Nonpharmacologic and Pharmacmentioning

confidence: 82%

The challenges of meeting the blood transfusion requirements in Sub-Saharan Africa: the need for the development of alternatives to allogenic blood

Erhabor

Charles²

2011

JBM

View full text Add to dashboard Cite

As a resource, allogenic blood has never been more in demand than it is today. Escalating elective surgery, shortages arising from a fall in supply, a lack of national blood transfusion services, policies, appropriate infrastructure, trained personnel, and financial resources to support the running of a voluntary nonremunerated donor transfusion service, and old and emerging threats of transfusion-transmitted infection, have all conspired to ensure that allogenic blood remains very much a vital but limited asset to healthcare delivery particularly in Sub-Saharan Africa. This is further aggravated by the predominance of family replacement and commercially remunerated blood donors, rather than regular benevolent, nonremunerated donors who give blood out of altruism. The demand for blood transfusion is high in Sub-Saharan Africa because of the high prevalence of anemia especially due to malaria and pregnancy-related complications. All stakeholders in blood transfusion have a significant challenge to apply the best available evidenced-based medical practices to the world-class management of this precious product in a bid to using blood more appropriately. Physicians in Sub-Saharan Africa must always keep in mind that the first and foremost strategy to avoid transfusion of allogenic blood is their thorough understanding of the pathophysiologic mechanisms involved in anemia and coagulopathy, and their thoughtful adherence to the evidenced-based good practices used in the developed world in a bid to potentially reduce the likelihood of allogenic blood transfusion in many patient groups. There is an urgent need to develop innovative ways to recruit and retain voluntary low-risk blood donors. Concerns about adverse effects of allogenic blood transfusion should prompt a review of transfusion practices and justify the need to search for transfusion alternatives to decrease or avoid the use of allogenic blood. These strategies should include the correction of anemia using pharmacological measures (use of antifibrinolytics to prevent bleeding and the use of erythropoietin and oral and intravenous iron to treat anemia) use of nonpharmacologic measures (preoperative autologous blood transfusion, perioperative red blood cell salvage and normothermia to reduce blood loss in surgical patients). All these strategies will help optimize the use of the limited blood stocks.

show abstract

“…Thus, implementation of alternatives to donor blood transfusion, such as salvage autotransfusion, has been considered. 3,4 Intravenous (IV) iron administration has been shown to be a useful tool for correcting anemia in a variety of clinical settings. 5 Once the patient is stabilized, full correction of postpartum anemia may be attained by administration of iron therapy with or without human recombinant erythropoietin.…”

Section: Introductionmentioning

confidence: 99%

Efficacy of Intravenous Iron for Treating Postpartum Anemia in Low-Resource African Countries: A Pilot Study in Malawi

Armand-Ugón

Cheong²,

Matapandewu³

et al. 2011

Journal of Women's Health

View full text Add to dashboard Cite

show abstract

Multicentre experience with a simple blood salvage technique in patients with ruptured ectopic pregnancy in sub‐Sahelian West Africa

Abstract: The surgical treatment of ruptured ectopic pregnancy with intraperitoneal haemorrhage was rendered safe and efficient with this new salvaging equipment.

Cited by 15 publications

References 13 publications

Taming the tide of HIV and TTI scourge in Sub-Saharan Africa using autologous blood transfusion

Taming the tide of HIV and TTI scourge in Sub-Saharan Africa using autologous blood transfusion

The challenges of meeting the blood transfusion requirements in Sub-Saharan Africa: the need for the development of alternatives to allogenic blood

Efficacy of Intravenous Iron for Treating Postpartum Anemia in Low-Resource African Countries: A Pilot Study in Malawi

Contact Info

Product

Resources

About